Advent Life Sciences is a leading brand that focuses on innovation, clarity, and execution in the life sciences sector. With an investment approach centered around understanding the true essence of innovative science and product concepts, Advent is committed to guiding companies from early stages all the way to market approval. Their hands-on approach involves working closely with founders and executives, sharing expertise and insights to refine business plans and develop effective strategies for scientific, clinical, and operational success.

Advent's track record speaks for itself, with their initial investments often made at the seed or Series A stage resulting in the approval of fifteen innovative medicines and products since 2006. As their mid- and late-stage clinical pipelines continue to grow, Advent remains a loyal and pragmatic partner, supporting the journey of their portfolio companies every step of the way